HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.075
Day range
$0.071 - $0.077
Year range
$0.061 - $0.15
Market cap
28.86M USD
Avg Volume
239.13K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Investing.com
1 hour ago
Nasdaq grants HCW Biologics extension to regain compliance with listing rules
0.067%
1.09%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 57.48K | -77.46% |
Operating expense | 874.18K | 94.73% |
Net income | -1.81M | -114.26% |
Net profit margin | -3.16K | -850.47% |
Earnings per share | — | — |
EBITDA | -1.68M | -159.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 385.93K | 1,204.65% |
Total assets | 722.38K | -15.65% |
Total liabilities | 6.60M | -21.18% |
Total equity | -5.87M | — |
Shares outstanding | 420.28M | — |
Price to book | -7.54 | — |
Return on assets | -603.32% | — |
Return on capital | 143.17% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.81M | -114.26% |
Cash from operations | -523.13K | 31.40% |
Cash from investing | — | — |
Cash from financing | 469.76K | -20.24% |
Net change in cash | -52.98K | 69.46% |
Free cash flow | 244.57K | 205.04% |
About
Founded
2002
Headquarters
Website
Employees
6
